Women’s Health Report Assesses first-in-class innovation with focus on endometriosis, polycystic ovarian syndrome and cervical intraepithelial neoplasia

This report assesses first-in-class innovation across the women’s health therapy area, with a particular focus on three key indications: endometriosis, polycystic ovarian syndrome (PCOS) and cervical intraepithelial neoplasia (CIN).

Pune, India - March 14, 2018 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population. Despite this, the women’s health market is relatively small. This reflects diagnostic barriers and high levels of non-treatment for women’s health disorders, as well as high levels of genericization and relatively limited innovation within recent decades.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline
Scope
• Many women’s health disorders are highly prevalent. How do epidemiology trends vary for endometriosis, PCOS and CIN?
• Innovation within women’s health has been relatively limited over recent decades. What are the most prominent unmet needs across this therapy area?
• There are 261 pipeline programs in active development for women’s health. What proportion of these products are first-in-class? How does first-in-class innovation vary by indication, development stage and molecular target class?
• Although the first-in-class pipeline is relatively modest in size it is considerably diverse with eight distinct molecular target classes represented. Which first-in-class targets have been identified as most promising for women’s health conditions?
• Over 200 licensing deals relating to women’s health have been completed since 2006. Do women’s health products typically attract high deal values? Which first-in-class products have prior deal involvement?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/987871
Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of symptoms, epidemiology, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment options.
• Visualize the composition of the women’s health market in terms of dominant molecule types and molecular targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
• Analyze the women’s health pipeline and stratify by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising first-in-class targets have been reviewed in greater detail.
• Recognize commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals, and identifying women’s health therapies that have not yet been involved in deals and may offer potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/987871

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/womens-health-report-assesses-first-in-class-innovation-with-focus-on-endometriosis-polycystic-ovarian-syndrome-and-cervical-intraepithelial-neoplasia/314337

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline%20%20

Source: MarketersMedia

Release ID: 314337

Latest News

Global stocks turn higher, price of oil keeps rising

Sep 25, 2018

BEIJING — Global stock markets turned higher Tuesday as investors parsed the latest news in the United States trade disputes, while the price of oil continued to gain on concerns that OPEC countries would not increase production. KEEPING SCORE: In Europe, France's CAC 40 gained 0.3 percent to 5,494 while London's FTSE 100 rose 0.5 percent to 7,494. Germany's DAX added 0.3 percent to 12,389. On Wall Street, futures for the Standard & Poor's 500 index and Dow Jones industrial average were both up 0.3 percent. ASIA'S DAY: The Shanghai Composite Index lost 0.6 percent to 2,781.14 while Tokyo's Nikkei...

China official says talks impossible with 'US holding knife'

Sep 25, 2018

BEIJING — China cannot hold talks with Washington on ending their escalating trade dispute while the United States "holds a knife" to Beijing's neck by imposing tariff hikes, a Chinese official said Tuesday. The warning came after the Chinese government released a report that accused President Donald Trump of bullying other countries. It dampened hopes for progress toward a settlement of their war over Beijing's technology policy. Trump went ahead Monday with a tax hike on $200 billion of Chinese imports. Beijing retaliated by imposing penalties on $60 billion of U.S. products. The conflict stems from U.S. complaints Beijing steals...

Trump plan to rollback fuel standards to get second hearing

Sep 25, 2018

FRESNO, Calif. — The Trump administration's proposal to roll back national fuel economy standards was headed for its second public hearing a day after California officials and scores of speakers blasted it as a danger to the environment and public health. The second hearing was scheduled for Tuesday in Dearborn, Michigan — a city in a region dominated by the auto industry where it could get a better reception. A major auto industry trade group says it supports annual increases in fuel efficiency, but it also says customers aren't buying more efficient cars. "No one wins if our customers are...

Trump and Macron: Realism replaces unlikely bromance

Sep 25, 2018

NEW YORK — French President Emmanuel Macron and U.S. President Donald Trump aren't as chummy as they used to be. When the two men met Monday in New York, they shook hands lightly and got down to business. They agreed to disagree on Iran's nuclear program and Trump's crackdown on global trade, according to two French presidential advisers. The progressive, globalist Macron appears to have lost hope that he could use his unlikely friendship with Trump to soften his protectionist, America-first policies. The White House said both leaders "reaffirmed their commitment to closely coordinate to address global challenges." The French...

Asian stocks lower on US-China trade worries

Sep 25, 2018

BEIJING — Asian stock markets were mostly lower Tuesday after a Chinese government report accusing the Trump administration of bullying other countries dampened hopes for a settlement in their escalating tariff war. KEEPING SCORE: The Shanghai Composite Index lost 0.8 percent to 2,775.91 and Sydney's S&P-ASX 200 shed 0.1 percent to 6,180.10. Tokyo's Nikkei 225 advanced 0.1 percent to 23,900.57 while Hong Kong and Seoul were closed for holidays. Benchmarks in New Zealand, Malaysia and the Philippines retreated while Taiwan and Singapore advanced. WALL STREET: Industrial companies and bank sank after news reports that China pulled out of possible talks...

Search
Financial Markets

About Us

Established in 2015, The Upstocker provides insights on financial reports, commentary, and investment data to traders so that you can make better investment decisions.

Contact us: sales[at]theupstocker.com

Subscribe Now!